Prothena Corp. plc Stock
Price
Target price
€5.50
€5.50
-1.850%
-0.1
-1.850%
€45.96
03.07.25 / Tradegate
WKN: A1KAVV / Symbol: PRTA / Name: Prothena Corp / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Prothena Corp. plc Stock
A loss of -1.850% shows a downward development for Prothena Corp. plc.
We see a rather positive sentiment for Prothena Corp. plc with 17 Buy predictions and 1 Sell predictions.
Based on the current price of 5.5 € the target price of 45 € shows a potential of 718.18% for Prothena Corp. plc which would more than double the current price.
For the coming years our community has positive and negative things to say abot the Prothena Corp. plc stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.
Pros and Cons of Prothena Corp. plc in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
S********** s********
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Prothena Corp. plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Prothena Corp. plc | -1.850% | 4.762% | 28.505% | -70.430% | -62.069% | -78.935% | -41.489% |
| Krystal Biotech | 0.370% | 2.066% | 4.579% | -26.369% | -20.466% | 95.242% | - |
| Ardelyx Inc. | -1.560% | 15.019% | 12.419% | -25.797% | -26.888% | 538.073% | -41.452% |
| Evolus Inc | -0.660% | -1.948% | -11.176% | -22.959% | -28.095% | -30.734% | 59.283% |
Comments
Prothena Co. plc (NASDAQ: PRTA) was downgraded by analysts at Bank of America Co. from a "neutral" rating to an "underperform" rating.
Show more
Ratings data for PRTA provided by MarketBeat
Prothena Co. plc (NASDAQ: PRTA) had its price target lowered by analysts at Piper Sandler from $110.00 to $81.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for PRTA provided by MarketBeat
Prothena Co. plc (NASDAQ: PRTA) had its price target lowered by analysts at Chardan Capital from $40.00 to $18.00. They now have a "buy" rating on the stock.
Show more
Ratings data for PRTA provided by MarketBeat